Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS

1996 • 8,991 citations

Revised Response Criteria for Malignant Lymphoma

2007 • 4,256 citations

Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

1999 • 3,484 citations

Evaluating the Yield of Medical Tests

1982 • 2,957 citations

Regression modelling strategies for improved prognostic prediction

1984 • 1,693 citations

Follicular lymphoma international prognostic index.

2004 • 1,553 citations

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

2004 • 1,395 citations

Follicular lymphoma international prognostic index

2006 • 1,262 citations

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

2004 • 971 citations

Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial

2006 • 595 citations

Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study

2003 • 584 citations

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

2003 • 519 citations

Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)

2005 • 457 citations

Natural history of and therapy for the indolent non-Hodgkin's lymphomas.

1993 • 412 citations

Follicular Lymphoma in the United States: First Report of the National LymphoCare Study

2009 • 280 citations

Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment

2004 • 227 citations

The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome

2006 • 215 citations

A strategy for modelling the effect of a continuous covariate in medicine and epidemiology

2000 • 214 citations

Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases

2000 • 186 citations

Serum beta₂ microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging.

1983 • 179 citations

The Clinical Significance of Molecular Response in Indolent Follicular Lymphomas

1998 • 165 citations

Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model.

1991 • 150 citations

Follicular lymphomas: Assessment of prognostic factors in 127 patients followed for 10 years

1991 • 112 citations

Prognostic Value of Serum β-2 Microglobulin in Low-Grade Lymphoma

1991 • 105 citations

Low-Grade Stage III-IV Follicular Lymphoma: Multivariate Analysis of Prognostic Factors in 484 Patients—A Study of the Groupe d'Etude des Lymphomes de l'Adulte

1999 • 92 citations

The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma

1991 • 82 citations

Follicular lymphomas: Assessment of prognostic factors in 127 patients followed for 10 years

1991 • 76 citations

β₂‐Microglobulin in Chronic Lymphocytic Leukaemia

1980 • 70 citations

Serum β2 microglobulin and its prognostic value in lymphomas

1979 • 65 citations

The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience.

1986 • 63 citations

Prognostic relevance of serum 2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study

2007 • 43 citations

An elevated serum beta‐2‐microglobulin level is an adverse prognostic factor for overall survival in patients with early‐stage Hodgkin disease

2002 • 41 citations

A Systematic Overview of Chemotherapy Effects in Indolent Non-Hodgkin's Lymphoma

2001 • 40 citations

Investigation about a screening step in model selection

2008 • 20 citations

Revalidation of FLIPI in patients with follicular lymphoma (FL) registered in the F2 study and treated upfront with immunochemotherapy

2007 • 6 citations